Admin, Author at Yas Holding
Interior & Architecture Designing
27/01/2023
Alvotech and Bioventure announce approval of AVT02 (adalimumab) as Simlandi in KSA
Alvotech (NASDAQ: ALVO) and Bioventure, announced that the Saudi Food & Drug Authority (“SFDA”) has approved the manufacturing and distribution of AVT02, a biosimilar for Humira® (adalimumab), which is commonly indicated for the treatment of rheumatoid arthritis and several other inflammatory diseases. The biosimilar will be marketed as Simlandi™ in Saudi Arabia. A biosimilar is
09/12/2022
Elite Agro UAE signs MoU with Lulu to promote locally grown vegetables
The agreement spans 15,000 Tons of Fresh produce Elite Agro Holding signed an MoU with Lulu Group, the leading hypermarket & supermarket chain to procure and promote locally grown vegetables. The MOU was signed by Dr Abdulmonem Almarzooqi, CEO of Elite Agro Holding and Saifee Rupawala, CEO of Lulu Group in the presence of HE
30/06/2022
Bioventure Healthcare FZE and GSK Sign Localisation Agreement to Manufacture Medicines
Global science-led UK healthcare company GlaxoSmithKline (GSK) has announced a new manufacturing agreement with our healthcare subsidiary, Bioventure Healthcare FZE (previously known as Geltec Healthcare FZE). Through this venture, GSK will transfer to the UAE the secondary packaging of 20 of its key products across several therapy areas, including the central nervous system, dermatology, urology,
28/06/2022
Geltec Healthcare FZE officially rebrands as Bioventure Healthcare FZE
GlobalOne Healthcare Holding (GHH), our Healthcare Division, announced the rebranding of its subsidiary Geltec Healthcare FZE as Bioventure Healthcare FZE, as part of its strategy to strengthen its business and drive growth in the pharmaceutical and supplement manufacturing industry. A strategic partner of multi-national companies and a key exporter to the U.S., Bioventure Healthcare FZE